Scott A Holmes - Net Worth and Insider Trading
Scott A Holmes Net Worth
The estimated net worth of Scott A Holmes is at least $1 Million dollars as of 2024-12-28. Scott A Holmes is the SVP, Finance and Treasurer of AMAG Pharmaceuticals Inc and owns about 51,958 shares of AMAG Pharmaceuticals Inc (AMAG) stock worth over $714,423. Scott A Holmes is also the CFO of Keryx Biopharmaceuticals Inc and owns about 162,956 shares of Keryx Biopharmaceuticals Inc (KERX) stock worth over $547,532. Details can be seen in Scott A Holmes's Latest Holdings Summary section.
Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the final shares held after open market or private purchases and sales of common stock with a transaction code of "P" or "S" on Form 4, assuming that Scott A Holmes has not made any transactions after 2018-11-15 and currently still holds the listed stock(s). Please note that this estimate may not reflect the actual net worth.
Transaction Summary of Scott A Holmes
Scott A Holmes Insider Ownership Reports
Based on ownership reports from SEC filings, as the reporting owner, Scott A Holmes owns 2 companies in total, including Keryx Biopharmaceuticals Inc (KERX) , and AMAG Pharmaceuticals Inc (AMAG) .
Click here to see the complete history of Scott A Holmes’s form 4 insider trades.
Insider Ownership Summary of Scott A Holmes
| Ticker | Comapny | Transaction Date | Type of Owner |
|---|---|---|---|
| KERX | Keryx Biopharmaceuticals Inc | 2018-12-12 | Chief Financial Officer |
| AMAG | AMAG Pharmaceuticals Inc | 2015-06-15 | SVP & Finance and Treasurer |
Scott A Holmes Latest Holdings Summary
Scott A Holmes currently owns a total of 2 stocks. Among these stocks, Scott A Holmes owns 51,958 shares of AMAG Pharmaceuticals Inc (AMAG) as of June 15, 2015, with a value of $714,423 and a weighting of 56.61%. Scott A Holmes also owns 162,956 shares of Keryx Biopharmaceuticals Inc (KERX) as of November 15, 2018, with a value of $547,532 and a weighting of 43.39%.
Latest Holdings of Scott A Holmes
| Ticker | Comapny | Latest Transaction Date | Shares Owned | Current Price ($) | Current Value ($) |
|---|---|---|---|---|---|
| AMAG | AMAG Pharmaceuticals Inc | 2015-06-15 | 51,958 | 13.75 | 714,423 |
| KERX | Keryx Biopharmaceuticals Inc | 2018-11-15 | 162,956 | 3.36 | 547,532 |
Holding Weightings of Scott A Holmes
Scott A Holmes Form 4 Trading Tracker
According to the SEC Form 4 filings, Scott A Holmes has made a total of 0 transactions in AMAG Pharmaceuticals Inc (AMAG) over the past 5 years. The most-recent trade in AMAG Pharmaceuticals Inc is the sale of 7,580 shares on June 15, 2015, which brought Scott A Holmes around $505,055.
According to the SEC Form 4 filings, Scott A Holmes has made a total of 0 transactions in Keryx Biopharmaceuticals Inc (KERX) over the past 5 years. The most-recent trade in Keryx Biopharmaceuticals Inc is the sale of 1,155 shares on November 15, 2018, which brought Scott A Holmes around $3,199.
Insider Trading History of Scott A Holmes
- 1
Scott A Holmes Trading Performance
GuruFocus tracks the stock performance after each of Scott A Holmes's buying transactions within different timeframes. To be detailed, the average return of stocks after 3 months bought by Scott A Holmes is -22.5%. GuruFocus also compares Scott A Holmes's trading performance to market benchmark return within the same time period. The performance of stocks bought by Scott A Holmes within 3 months outperforms 0 times out of 2 transactions in total compared to the return of S&P 500 within the same period.
You can select different timeframes to see how Scott A Holmes's insider trading performs compared to the benchmark.
Performance of Scott A Holmes
Average Return
Outperforming Transactions
| 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | 3 Years | |
|---|---|---|---|---|---|---|
| Return(%) | -17.16 | | | | | |
| Relative Return to S&P 500(%) | -16.8 | | | | | |
Scott A Holmes Ownership Network
Scott A Holmes Owned Company Details
What does Keryx Biopharmaceuticals Inc do?
Who are the key executives at Keryx Biopharmaceuticals Inc?
Scott A Holmes is the Chief Financial Officer of Keryx Biopharmaceuticals Inc. Other key executives at Keryx Biopharmaceuticals Inc include director & Interim CEO Jodie Pope Morrison , 10 percent owner Seth A Klarman , and director & 10 percent owner Baupost Group Llc/ma .
Keryx Biopharmaceuticals Inc (KERX) Insider Trades Summary
In summary, during the past 3 months, insiders sold 0 shares of Keryx Biopharmaceuticals Inc (KERX) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Keryx Biopharmaceuticals Inc (KERX) were sold and 0 shares were bought by its insiders, resulting in a net sale of 0 shares.
Keryx Biopharmaceuticals Inc (KERX)'s detailed insider trading history can be found in Insider Trading Tracker table.
Keryx Biopharmaceuticals Inc Insider Transactions
Scott A Holmes Mailing Address
Above is the net worth, insider trading, and ownership report for Scott A Holmes. You might contact Scott A Holmes via mailing address: C/o Keryx Biopharmaceuticals Inc 1 Marina Park Dr., 10th Floor Boston Ma 02210.
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
